UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057292 |
|---|---|
| Receipt number | R000065488 |
| Scientific Title | Effect of tart cherry juice intake on fatigue during multiple exercise |
| Date of disclosure of the study information | 2025/03/14 |
| Last modified on | 2025/03/18 02:21:55 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effect of Tart Cherry Juice Intake on Fatigue in Exercise
Acronym
Tart Cherry Intake and Fatigue
Scientific Title
Effect of tart cherry juice intake on fatigue during multiple exercise
Scientific Title:Acronym
Effect of tart cherry juice on fatigue during multiple exercise
Region
| Japan |
Condition
Condition
Healthy adults
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this study is to investigate whether tart cherry juice supplementation attenuates declines in endurance and anaerobic performance and neuromuscular function in repeated cycling exercise.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Endurance and anaerobic performance and neuromuscular function, maximal voluntary contraction and force steadiness
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Participants consumed either 200 g of tart cherry juice [30 mL of tart cherry concentrate (Cherry Active) diluted with water] twice daily for 7 days before exercise and 100 minutes before exercise.
Interventions/Control_2
Participants consumed 200 g of a placebo beverage [0.38 g of flavored drink powder (Kool-Aid) diluted with water and supplemented with 27.8 g of maltodextrin] twice daily for 7 days before exercise and 100 minutes before exercise.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male
Key inclusion criteria
Male students enrolled at Toyo University or healthy men aged 18 years or older who regularly engage in endurance training.
Key exclusion criteria
Individuals with a history of hypertension or cardiovascular disease
Current or former smokers
Individuals who regularly consume supplements containing antioxidants
Target sample size
15
Research contact person
Name of lead principal investigator
| 1st name | Kana |
| Middle name | |
| Last name | Konishi |
Organization
Toyo University
Division name
Faculty of Health and Sports Sciences
Zip code
1158650
Address
1-7-11 Akabanedai, Kita ku, Tokyo, Japan
TEL
0359242822
konishi@toyo.jp
Public contact
Name of contact person
| 1st name | Kana |
| Middle name | |
| Last name | Konishi |
Organization
Toyo University
Division name
Faculty of Health and Sports Sciences
Zip code
3330802
Address
1-7-11 Akabanedai, Kita ku, Tokyo, Japan
TEL
0276829208
Homepage URL
eka5250@gmail.com
Sponsor or person
Institute
Toyo University
Institute
Department
Personal name
Funding Source
Organization
Toyo University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Toyo University Ethical Review Board for Medical and Health Research Involving Human Subjects
Address
2100 Kujirai, Kawagoe city, Saitama, Japan
Tel
0492391440
mlkks@toyo.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 03 | Month | 14 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2024 | Year | 07 | Month | 01 | Day |
Date of IRB
| 2024 | Year | 10 | Month | 03 | Day |
Anticipated trial start date
| 2024 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 03 | Month | 14 | Day |
Last modified on
| 2025 | Year | 03 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065488
